Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet.

Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored.

You can separately subscribe to the Pharma & Biotech Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: http://thinkipstrategy.com/subscribe/

Highlights this week included:

European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360) (Patent Docs) (GenericsWeb) (IPKat) (Excess Copyright)

USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360) (Law360)

General

Teva grabs billions gambling on copies of brand drugs (GenericsWeb)

Patent insurance: a financial prescription for neglected diseases? (IP finance)

Genomics-based patents: are prophetic assertions of utility enough? (Holman’s Biotech IP Blog)

IP and genetically modified organisms: a fateful combination, activists say (Intellectual Property Watch)

Australia: Gene patent delays diagnosis and treatment for babies with severe form of epilepsy: (Techdirt)

Brazil: Brazilian draft law would curb expanded patents on pharmaceuticals (Intellectual Property Watch) (IP tango)

EU: European Commission issues preliminary report on its inquiry into competition in the pharmaceutical sector (IPKat) (Copyfight) (IAM) (Managing Intellectual Property) (Law360) (Patent Docs) (GenericsWeb) (IPKat) (Excess Copyright)

EU: EPO rejects WARF’s application due to embryo destruction (Copyfight) (Managing Intellectual Property) (Holman’s Biotech IP Blog) (Hal Wegner)

Germany: Solvay sues USPTO over refusal to extend patent (Law360)

India: Indian IP laws: troubled waters (Patent Circle)

Lithuania: SPCs in Lithuania (The SPC Blog)

US: Last call! FDA issues draft guidance on submission of patent information for certain old antibiotics (FDA Law Blog)

US: FDA publishes new guidance on contents of a complete submission for the evaluation of proprietary names (FDA Law Blog)

USPTO appeals Wyeth v Dudas decision on patent term adjustment calculation; more patentees (including Molecular Insight and Biogen) follow Wyeth’s lead in seeking additional patent term adjustment (IP Updates) (Patent Docs) (Law360) (Patent Docs) (Law360) (Law360)

Products

Amrix (Cyclobenzaprine) – US: Cephalon and Eurand file patent infringement lawsuit against Mylan and Barr; Barr, Mylan confirms challenge of Amrix patent (SmartBrief) (SmartBrief) (SmartBrief) (GenericsWeb)

Antara (Fenofibrate) – US: Lupin files ANDA for generic Antara, challenging validity of Oscient’s patent (Law360) (GenericsWeb)

Boniva (Ibandronic acid) – US: Roche, Dr Reddy’s drop one patent in Boniva suit (Law360)

Coreg (Carvedilol) – US: Glenmark files counterclaims of engaging in ‘sham’ litigation and antitrust violations in Coreg patent battle with Teva (Law360)

Enbrel (Etanercept) – US: ARIAD appeals summary judgment of non-infringement in favour of Amgen (PATracer)

Femara (Letrozole) – US: Mylan, Novartis settle patent dispute over generic Femara (Law360) (GenericsWeb)

Glivec (Imatinib) – India: Glivec and selection patent – Intellectual Property Appellate Board begins hearing Glivec case (Spicy IP)

Lefax (Simeticon) – Germany: Bundesgerichtshof’s Lefax/Lefaxin decision on use of importers’ trade marks on parallel imported pharmaceuticals (Class 46)

Mircera (Recombinant erythropoietin) – US: Hoffman-La Roche appeals from the judgment of Judge W Young finding that it infringes Amgen’s EPO patents (PATracer)

Coversyl (Perindopril) – Canada: Settlement of patent conflict did not contravene Competition Act: Les Laboratoires Servier v Apotex (International Law Office)

Q-Drench (Abamectin, Albendazole, Closantel, Levamisole) – Australia: Infringement and validity of innovation patents; Full Court upholds decision in favour of respondent: Nufarm Limited v Jurox Pty Limited (IPRoo)

Solodyn (Minocycline) – US: Impax able to move forward with marketing generic Solodyn after resolving patent dispute with Medici (Law360) (Patent Docs)

Travatan (Travoprost) – India: Pre-preliminary injunction granted in favour of Alcon in trade mark and copyright action against Ajanta over the use of TRAXAVO for travoprost eyedrops and identical product information inserts (IPKat)

Valcyte (Valgancyclovir) – India: Madras High Court orders re-examination of Roche’s Valcyte patent in action brought by Indian Network of Positive People (Patent Circle) (Patent Circle)